Systematic searches for plasma proteins that are biological indicators, or biomarkers, for
cancer are underway. The difficulties caused by the complexity of biological-fluid proteomes …

The ability to measure the abundance of many proteins precisely and simultaneously in
experimental samples is an important, recent advance for static and dynamic, as well as …

Protein resistant or “non‐fouling” surfaces are of great interest for a variety of biomedical and
biotechnology applications. This article briefly reviews the development of protein resistant …

The focus of this article is to review the recent advances in proteome analysis of human
body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar …

The objective of this study was to review and summarise the published evidence for an
association between circulating concentrations of C reactive protein (CRP) and cancer …

Rationale: Much of the total disease burden and cost of chronic obstructive pulmonary
disease (COPD) is associated with acute exacerbations of COPD (AECOPD). Serum …

The synthesis of acute-phase protein serum amyloid A (SAA) is largely regulated by
inflammation-associated cytokines and a high concentration of circulating SAA may …

Background Lung cancer is the leading cause of cancer deaths worldwide. New diagnostics
are needed to detect early stage lung cancer because it may be cured with surgery …

Lung cancer remains to be the leading cause of cancer-related mortality worldwide. Finding
new noninvasive biomarkers for lung cancer is still a significant clinical challenge …

Antibody arrays are valuable for the parallel analysis of multiple proteins in small sample
volumes. The earliest and most widely used application of antibody arrays has been to …